RVPH Earnings & Financial Statements
Reviva Pharmaceuticals Holdings, Inc.
$0.48
-$0.02(-3.45%)
17
Overall
--
Value
20
Tech
15
Quality
Market Cap
$6.49M
Volume
23.54K
52W Range
$0.26 - $15.40
Target Price
$17.50
RVPH earnings and financial statements: Reviva Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
RVPH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$20.20M | -$30.80M | -$39.50M | -$28.23M | -$10.10M |
| EBITDA | -$19.83M | -$29.88M | -$39.24M | -$28.23M | -$8.51M |
| Net income | -$19.86M | -$29.92M | -$39.26M | -$28.26M | -$8.52M |
| EPS (diluted) | $-5.48 | $-18.00 | $-33.00 | $-25.00 | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $15.92M | $15.50M | $23.70M | $18.92M | $31.40M |
| Total liabilities | $7.28M | $14.69M | $17.98M | $10.53M | $2.72M |
| Shareholders’ equity | $8.65M | $812.6K | $5.72M | $8.39M | $28.69M |
| Cash and equivalents | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M |
| Free cash flow | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVPH | $0.48 | -3.5% | 23.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Reviva Pharmaceuticals Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW